The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pathophysiology of Spironolactone-Induced Gynecomastia
Abstract
Peripheral blood levels of testosterone, estradiol, luteinizing hormone, and follicle-stimulating hormone and the metabolic clearance rates of testosterone and estradiol, as well as the peripheral conversion of testosterone into estradiol, were measured in 16 patients with hypertension. Six of these patients were treated with spironolactone and developed gynecomastia. The other 10 patients served as control subjects. The blood testosterone level in the spironolactone-treated group (2.7 +/- 0.5 ng/ml) was significantly less (P less than 0.02) than in the control group (4.4 +/- 0.4 ng/ml). On the other hand, blood estradiol levels in the spironolactone group (30 +/- 4 pg/ml) were significantly greater (P less than 0.01) than in the control group (13 +/- 2 pg/ml). These changes were primarily due to significant increases in the metabolic clearance rate of testosterone (P less than 0.02) and in the rate of peripheral conversion of testosterone into estradiol (P less than 0.001) in the spironolactone-treated group. Thus, spironolactone does alter the peripheral metabolism of testosterone resulting in changes in the ratio of testosterone to estradiol, which could contribute to the production of gynecomastia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MENARD, R. H., STRIPP, B., & GILLETTE, J. R. (1974) · Endocrinology · doi:10.1210/endo-94-6-1628 · Cited by 117
Kley, H. K., Nieschlag, E., Wiegelmann, W., Solbach, H. G., & Krüskemper, H. L. (1975) · Acta Endocrinologica · doi:10.1530/acta.0.0790275 · Cited by 98
Cited by
Efficacy and tolerance of spironolactone in essential hypertension
Jeunemaitre, X., Chatellier, G., Kreft-Jais, C., Charru, A., Devries, C., Plouin, P.-F., Corvol, P., & Menard, J. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91030-7 · Cited by 276
The endocrine effects of spironolactone used as an antiandrogen
Young, R. L., Goldzieher, J. W., & Elkind-Hirsch, K. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59346-7 · Cited by 38
Metadata
- Authors
- ROSE, L. I., UNDERWOOD, R. H., NEWMARK, S. R., KISCH, E. S., & WILLIAMS, G. H.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1977-10-01
- Volume
- 87
- Issue
- 4
- Pages
- 398-403
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2092786209
- Cited by
- 193
- References
- 2
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiology of Spironolactone-Induced Gynecomastia. https://app.cochat.ai/papers/10.7326/0003-4819-87-4-398
- The paper
- ROSE, L. I., UNDERWOOD, R. H., NEWMARK, S. R., KISCH, E. S., & WILLIAMS, G. H. (1977). Pathophysiology of Spironolactone-Induced Gynecomastia. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-87-4-398
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.